Evidence map›Paper›PMID 33972668›Full record

ArticleCommunications biology2021

Mitofusin-2 boosts innate immunity through the maintenance of aerobic glycolysis and activation of xenophagy in mice.

Prashanta Silwal, Jin Kyung Kim, Sang Min Jeon, June-Young Lee, Young Jae Kim, Yi Sak Kim, Yeji Seo, Jihye Kim, Soo Yeon Kim, Min Joung Lee and 12 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 3 countries.

Prashanta Silwal *Department of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea.ORCID http://orcid.org/0000-0002-8332-024X
Jin Kyung Kim *Department of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea.ORCID http://orcid.org/0000-0002-2051-5787
Sang Min JeonDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea.
June-Young LeeDepartment of Life and Nanopharmaceutical Sciences and Department of Biology, Kyung Hee University, Seoul, Korea.
Young Jae KimDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea.
Yi Sak KimDepartment of Medicine, University of California, San Diego, CA, USA.
Yeji SeoDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
Jihye KimDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
Soo Yeon KimFuture Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Korea.
Min Joung LeeInfection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, Korea.
Jun Young HeoInfection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, Korea.
Mi-Ja JungDepartment of Life and Nanopharmaceutical Sciences and Department of Biology, Kyung Hee University, Seoul, Korea.
Hyun Sik KimDepartment of Life and Nanopharmaceutical Sciences and Department of Biology, Kyung Hee University, Seoul, Korea.
Dong-Wook HyunDepartment of Life and Nanopharmaceutical Sciences and Department of Biology, Kyung Hee University, Seoul, Korea.
Jeong Eun HanDepartment of Life and Nanopharmaceutical Sciences and Department of Biology, Kyung Hee University, Seoul, Korea.
Jake WhangKorea Mycobacterium Resource Center (KMRC) & Basic Research Section, The Korean Institute of Tuberculosis (KIT), Cheongju, Korea.ORCID http://orcid.org/0000-0003-4444-508X
Yang Hoon HuhCenter for Research Equipment, Korea Basic Science Institute, Cheongju, Korea.
Sang-Hee LeeCenter for Research Equipment, Korea Basic Science Institute, Cheongju, Korea.
Won Do HeoDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
Jin-Man KimDepartment of Pathology, Chungnam National University School of Medicine, Daejeon, Korea.
Jin-Woo BaeDepartment of Life and Nanopharmaceutical Sciences and Department of Biology, Kyung Hee University, Seoul, Korea.ORCID http://orcid.org/0000-0001-6433-5270
Eun-Kyeong JoDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea. hayoungj@cnu.ac.kr.ORCID http://orcid.org/0000-0001-7191-0587
Chungnam National University · KRKyung Hee University · KRKorea Advanced Institute of Science and Technology · KRKorea Basic Science Institute · KRKorea Institute of Oriental Medicine · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial function and innate immunity are intimately linked; however, the mechanisms how mitochondrion-shaping proteins regulate innate host defense remains largely unknown. Herein we show that mitofusin-2 (MFN2), a mitochondrial fusion protein, promotes innate host defense through the maintenance of aerobic glycolysis and xenophagy via hypoxia-inducible factor (HIF)-1α during intracellular bacterial infection. Myeloid-specific MFN2 deficiency in mice impaired the antimicrobial and inflammatory responses against mycobacterial and listerial infection. Mechanistically, MFN2 was required for the enhancement of inflammatory signaling through optimal induction of aerobic glycolysis via HIF-1α, which is activated by mitochondrial respiratory chain complex I and reactive oxygen species, in macrophages. MFN2 did not impact mitophagy during infection; however, it promoted xenophagy activation through HIF-1α. In addition, MFN2 interacted with the late endosomal protein Rab7, to facilitate xenophagy during mycobacterial infection. Our findings reveal the mechanistic regulations by which MFN2 tailors the innate host defense through coordinated control of immunometabolism and xenophagy via HIF-1α during bacterial infection.

Indexed as

GlycolysisMacroautophagyAnimalsBacteriaBacterial InfectionsGTP PhosphohydrolasesImmunity, InnateMacrophagesMiceMice, Inbred C57BLMice, KnockoutMitochondriaReactive Oxygen SpeciesSignal TransductionGTP PhosphohydrolasesMfn2 protein, mouseReactive Oxygen Species

Identifiers

PMID33972668
PMCPMC8110749
OpenAlexW3163883992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.